Patents by Inventor Martin Cooper

Martin Cooper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060052380
    Abstract: The invention relates to thienopyridazinones of formula (I): wherein: R1 is C1-6 alkyl, C2-6 alkenyl or C3-6 cycloalkyl which is optionally substituted by C1-6 alkyl, each of the above being optionally substituted by one or more halogen atoms; R2 is C1-6 alkyl; R3 is a group CO-G or SO2-G where G is a 5- or 6-membered ring containing a nitrogen atom and a second heteroatom selected from oxygen and sulphur adjacent to the nitrogen, and optionally substituted by up to 3 groups selected from hydroxyl and C1-4 alkyl; Q is CR5R6 where R5 and R6 are as defined in the specification; and R4 is a 5- to 10-membered mono- or bi-cyclic aromatic ring system, containing 0 to 4 heteroatoms independently selected from nitrogen, oxygen and sulphur, the ring system being optionally substituted as described in the specification, and pharmaceutically acceptable salts and solvates thereof.
    Type: Application
    Filed: January 15, 2004
    Publication date: March 9, 2006
    Inventors: Martin Cooper, Simon Guile, Anthony Ingall, Rukhsana Rasul
  • Patent number: 6984644
    Abstract: The invention provides pharmaceutically useful thieno[2,3-d]pyrimidinediones, processes for their production, pharmaceutical compositions containing them and methods of treatment involving their use.
    Type: Grant
    Filed: October 7, 2002
    Date of Patent: January 10, 2006
    Assignee: AstraZeneca AB
    Inventors: David Cheshire, Andrew Cooke, Martin Cooper, David Donald, Mark Furber, Matthew Perry, Philip Thorne
  • Patent number: 6844857
    Abstract: A container (10) (or other returnable item) for the storage and delivery of goods, comprises antenna means (16) for radio frequency use, and connection means (18) for receiving a removable drive circuit means (20). The drive circuit (20) is operable to communicate by means of the antenna (16) when connected therewith. The connections (18) serve, in use, to connect an installed drive circuit (20) with the antenna (16) to allow the drive circuit (20) to communicate. This allows the identity of the container or its contents to be communicated to a remote location.
    Type: Grant
    Filed: March 5, 2001
    Date of Patent: January 18, 2005
    Assignee: Linpac Mouldings Limited
    Inventors: Stephen Clive Loftus, Martin Cooper
  • Patent number: 6770646
    Abstract: The invention provides certain pyrrolo-, thieno-, furano-and pyrazolo-[3,4-d]-pyridazinones, processes for their preparation, pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions, and methods of treatment involving their use.
    Type: Grant
    Filed: December 10, 2001
    Date of Patent: August 3, 2004
    Assignee: AstraZeneca AB
    Inventors: John Bantick, Martin Cooper, Philip Thorne, Matthew Perry
  • Publication number: 20030191142
    Abstract: The invention provides pharmaceutically useful thieno[2,3-d]pyrimidinediones, processes for their production, pharmaceutical compositions containing them and methods of treatment involving their use.
    Type: Application
    Filed: October 7, 2002
    Publication date: October 9, 2003
    Applicant: AstraZeneca AB
    Inventors: David Cheshire, Andrew Cooke, Martin Cooper, David Donald, Mark Furber, Matthew Perry, Philip Thorne
  • Publication number: 20030179092
    Abstract: A container (10) (or other returnable item) for the storage and delivery of goods, comprises antenna means (16) for radio frequency use, and connection means (18) for receiving a removable drive circuit means (20). The drive circuit (20) is operable to communicate by means of the antenna (16) when connected therewith. The connections (18) serve, in use, to connect an installed drive circuit (20) with the antenna (16) to allow the drive circuit (20) to communicate. This allows the identity of the container or its contents to be communicated to a remote location.
    Type: Application
    Filed: April 7, 2003
    Publication date: September 25, 2003
    Inventors: Stephen Clive Loftus, Martin Cooper
  • Publication number: 20020183337
    Abstract: The invention provides pharmaceutically useful thieno[2,3-d]pyrimidinediones, processes for their production, pharmaceutical compositions containing them and methods of treatment involving their use.
    Type: Application
    Filed: October 17, 2001
    Publication date: December 5, 2002
    Applicant: AstraZeneca AB.
    Inventors: David Cheshire, Andrew Cooke, Martin Cooper, David Donald, Mark Furber, Matthew Perry, Philip Thorne
  • Patent number: 6469014
    Abstract: The invention provides pharmaceutically useful thieno[2,3-d]pyrimidinediones, processes for their production, pharmaceutical compositions containing them and methods of treatment involving their use.
    Type: Grant
    Filed: October 17, 2001
    Date of Patent: October 22, 2002
    Assignee: AstraZeneca AB
    Inventors: David Cheshire, Andrew Cooke, Martin Cooper, David Donald, Mark Furber, Matthew Perry, Philip Thorne
  • Publication number: 20020108398
    Abstract: In order to produce on the table of a diamond gemstone, an information mark which is invisible to the naked eye using a x10 loupe, an ultraviolet laser having a wavelength of 193 nm is used in association with a mask irradiate the surface of the stone at a fluence of less that 2 J/cm2 per pulse and with not fewer than 100 pulses, in the presence of air which reacts with the diamond and causes the mark to be formed without any darkening which is visible when viewing a microscope.
    Type: Application
    Filed: April 2, 2002
    Publication date: August 15, 2002
    Inventors: James Gordon Charters Smith, Martin Cooper
  • Publication number: 20020099055
    Abstract: The invention provides certain pyrrolo-, thieno-, furano-and pyrazolo-[3,4-d]-pyridazinones, processes for their preparation, pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions, and methods of treatment involving their use.
    Type: Application
    Filed: December 10, 2001
    Publication date: July 25, 2002
    Applicant: AstraZeneca AB.
    Inventors: John Bantick, Martin Cooper, Philip Thorne, Matthew Perry
  • Patent number: 6342502
    Abstract: The invention provides pharmaceutically useful thieno[2,3-d]pyrimidinediones, processes for their production, pharmaceutical compositions containing them and methods of treatment involving their use.
    Type: Grant
    Filed: October 23, 2000
    Date of Patent: January 29, 2002
    Assignee: AstraZeneca AB
    Inventors: David Cheshire, Andrew Cooke, Martin Cooper, David Donald, Mark Furber, Matthew Perry, Philip Thorne
  • Patent number: 6342601
    Abstract: The invention provides certain pyrrolo-, thieno-, furano- and pyrazolo-[3,4-d]pyridazinones, processes for their preparation, pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions, and methods of treatment involving their use.
    Type: Grant
    Filed: January 12, 1999
    Date of Patent: January 29, 2002
    Assignee: AstraZeneca AB
    Inventors: John Bantick, Martin Cooper, Philip Thorne, Matthew Perry
  • Patent number: 6300334
    Abstract: Compounds of formula (I): wherein R1, R2, and R3 are defined in the specification. The compounds are useful for treating or reducing the risk of reversible obstructive airways disease.
    Type: Grant
    Filed: October 13, 1999
    Date of Patent: October 9, 2001
    Assignee: AstraZeneca AB
    Inventors: John Bantick, Martin Cooper, Matthew Perry, Philip Thorne
  • Patent number: 6187213
    Abstract: In order to produce on the table of a diamond gemstone (7), an information mark which is invisible to the naked eye using a ×10 loupe, an ultraviolet laser (1) having a wavelength of 193 nm is used in association with a mask (2) to irradiate the surface of the stone (7) at a fluence of less than 2 J/cm2 per pulse and with not fewer than 100 pulses, in the presence of air which reacts with the diamond (7) and causes the mark to be formed without any darkening which is visible when viewing using a microscope.
    Type: Grant
    Filed: May 15, 1998
    Date of Patent: February 13, 2001
    Assignee: Gersan Establishment
    Inventors: James Gordon Charters Smith, Martin Cooper
  • Patent number: 6180635
    Abstract: The invention provides pharmaceutically useful thieno[2,3-d]pyrimidinediones, processes for their production, pharmaceutical compositions containing them and methods of treatment involving their use.
    Type: Grant
    Filed: July 30, 1998
    Date of Patent: January 30, 2001
    Assignee: AstraZeneca UK Limited
    Inventors: David Cheshire, Andrew Cooke, Martin Cooper, David Donald, Mark Furber, Matthew Perry, Philip Thorne
  • Patent number: 6143751
    Abstract: Compounds of the formula (I) wherein X, R.sup.1, R.sup.2, and Ar.sup.1 as defined in the specification. The compounds are useful medicaments, particularly in the treatment of asthma or rhinitis.
    Type: Grant
    Filed: May 11, 1998
    Date of Patent: November 7, 2000
    Assignee: AstraZeneca UK Limited
    Inventors: David Cheshire, David Cladinggboel, Martin Cooper, David Hardern, Simon Hirst, Carol Manners, Michael Stocks
  • Patent number: 6034688
    Abstract: A user-interface system adapted to navigate through a plurality of menus is disclosed. The system comprises a display system comprising a display having a category area on a first portion of the display, the category area displaying a plurality of categories, including a currently displayed category. Each of the plurality of categories has a plurality of items. The display also has a marquee area on a second portion of the display, which displays items of the currently displayed category. The system further comprises a scrolling mechanism for scrolling through items of each category of the plurality of categories. The marquee area is updated by the scrolling mechanism to display the corresponding items in each category. The scrolling mechanism also indicates a position of a currently displayed item of a currently displayed category by updating the category area. Various embodiments are disclosed.
    Type: Grant
    Filed: September 15, 1997
    Date of Patent: March 7, 2000
    Assignees: Sony Corporation, Sony Trans Com Inc.
    Inventors: Wayne Eugene Greenwood, Alan Martin Cooper, Karen Louise Evensen
  • Patent number: 6028074
    Abstract: The invention relates to pharmaceutically useful pyrazolo[3,4-d]pyrimidinedione compounds, processes for their production, pharmaceutical compositions containing them and their use for the treatment of various diseases.
    Type: Grant
    Filed: May 7, 1998
    Date of Patent: February 22, 2000
    Assignee: Astra Pharmaceuticals, Ltd.
    Inventors: David Cheshire, Martin Cooper, David Donald, Philip Thorne
  • Patent number: 6014208
    Abstract: In order to test whether a diamond has had a layer of synthetic diamond deposited thereon, it is irradiated with high energy ultraviolet radiation to cause emission of luminescence, the luminescence intensity produced by different zones of the diamond being measured and compared. In one embodiment an integrating enclosure (15) is used and the diamond (13) is mounted on a rotatable mount (14).
    Type: Grant
    Filed: March 27, 1998
    Date of Patent: January 11, 2000
    Assignee: Gersan Establishment
    Inventors: Christopher Mark Welbourn, Martin Phillip Smith, James Gordon Charters Smith, Paul Martyn Spear, Philip Maurice Martineau, Martin Cooper
  • Patent number: D407498
    Type: Grant
    Filed: September 30, 1997
    Date of Patent: March 30, 1999
    Inventor: Martin Cooper